Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Laguna Hills, USA
26051 Merit Circle
Suite 103
Laguna Hills, CA, 92653
USA

People

Chairman of the Board
Board of Directors
Board of Directors
Board of Director
Board of Directors
Board Observer/Investor
Scientific Advisory Board
Scientific Advisory Board
Show All People

Funding

Tags

Glaukos

Glaukos Corporation is committed to transforming glaucoma therapy. To this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiologic outflow as a foundation of significant, steady and sustained glaucoma management. Today, they are at the beginning with an innovative micro technology. In collaboration with their clinician partners, they are building technology towards a safer and more effective treatment for preserving vision in patients with primary open-angle glaucoma.

Recent Milestones

  • Dollar
    Glaukos received $30M in Series F funding. (2/7/13)
    Posted 2/7/13 at 8:17pm via dowjones.com
  • Dollar
    Glaukos received $6M in Debt funding. (10/3/12)
    Posted 7/18/13 at 1:58am via sec.gov
  • Dollar
    Glaukos received $4.5M in Debt funding. (8/10/12)
    Posted 7/29/13 at 10:12pm via sec.gov
  • Dollar
    Glaukos received $29.5M in Series E funding. (2/2/11)
    Posted 2/2/11 at 11:01pm via dowjones.com
  • Dollar
    Glaukos received $6M in Debt funding. (9/23/10)
    Posted 1/31/14 at 2:02am via sec.gov
  • Dollar
    Glaukos received $35M in Series D funding. (8/29/08)
    Posted 6/22/09 at 8:17pm via equityhelpdesk.com
  • Dollar
    Glaukos received $10M in Series A funding. (9/1/02)
    Posted 2/9/13 at 5:43am via privco.com

Videos

Screenshots

Glaukos screenshot
Above: Glaukos
Uploaded: 6/23/09

Sources

  1. Glaukos Receives Series A Investment From Domain Associates, LLC, Versant Ventures, And Frazier Healthcare Ventures (privco.com) [edit]
  2. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
  3. SEC (sec.gov) [edit]
  4. Glaukos Sees $29.5M Series E Round For Tiny Eye Device (fis.dowjones.com) [edit]
  5. SEC (sec.gov) [edit]
  6. SEC (sec.gov) [edit]
  7. Glaukos Spots $30M for Eyeball Stent, Doesn't Blink in Ivantis Rivalry (pevc.dowjones.com) [edit]
Edit This Page
Last Edited 3/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy